Simplex Trading, LLC Iovance Biotherapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 155,572 shares of IOVA stock, worth $1.34 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

155,572

Previous 84,722 83.63%

Holding current value

$1.34 Million

Previous $679,000 115.02%

% of portfolio

0.05%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$7.28 - $11.9 $515,788 - $843,115	70,850 Added 83.63%	155,572 $1.46 Million
Q2 2024 Jul 25, 2024	BUY	$7.78 - $14.19 $400,880 - $731,168	51,527 Added 155.23%	84,722 $679,000
Q1 2024 Apr 25, 2024	SELL	$7.59 - $17.47 $2.59 Million - $5.96 Million	-340,872 Reduced 91.13%	33,195 $491,000
Q4 2023 Feb 02, 2024	BUY	$3.3 - $8.89 $655,545 - $1.77 Million	198,650 Added 113.24%	374,067 $3.04 Million
Q3 2023 Nov 01, 2023	BUY	$4.44 - $8.79 $441,225 - $873,506	99,375 Added 130.68%	175,417 $798,000
Q2 2023 Aug 04, 2023	BUY	$5.36 - $9.06 $281,217 - $475,341	52,466 Added 222.54%	76,042 $535,000
Q1 2023 Apr 27, 2023	BUY	$5.53 - $8.22 $130,375 - $193,794	23,576 New	23,576 $144,000
Q3 2022 Nov 04, 2022	BUY	$9.53 - $13.11 $3,287 - $4,522	345 New	345 $3,000
Q2 2022 Aug 03, 2022	SELL	$6.38 - $18.33 $169,101 - $485,836	-26,505 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$12.38 - $19.1 $352,470 - $543,796	-28,471 Reduced 51.79%	26,505 $441,000
Q4 2021 Feb 23, 2022	BUY	$16.55 - $27.63 $909,852 - $1.52 Million	54,976 New	54,976 $1.05 Million
Q2 2021 Aug 12, 2021	SELL	$16.33 - $33.07 $168,639 - $341,513	-10,327 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$28.67 - $52.59 $296,075 - $543,096	10,327 New	10,327 $0
Q4 2020 Feb 02, 2021	SELL	$28.04 - $50.26 $346,546 - $621,163	-12,359 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$27.75 - $36.3 $342,962 - $448,631	12,359 New	12,359 $406,000
Q2 2020 Jul 13, 2020	SELL	$27.21 - $41.0 $676,848 - $1.02 Million	-24,875 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$19.54 - $38.85 $15,807 - $31,429	809 Added 3.36%	24,875 $744,000
Q4 2019 Feb 05, 2020	BUY	$17.95 - $29.41 $185,297 - $303,599	10,323 Added 75.11%	24,066 $666,000
Q3 2019 Oct 15, 2019	SELL	$17.99 - $26.0 $98,801 - $142,792	-5,492 Reduced 28.55%	13,743 $250,000
Q2 2019 Jul 26, 2019	BUY	$9.78 - $24.52 $188,118 - $471,642	19,235 New	19,235 $471,000
Q1 2019 Apr 18, 2019	SELL	$8.41 - $11.26 $18,199 - $24,366	-2,164 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$7.51 - $11.93 $8,741 - $13,886	1,164 Added 116.4%	2,164 $19,000
Q3 2018 Oct 23, 2018	SELL	$11.25 - $17.7 $173,576 - $273,093	-15,429 Reduced 93.91%	1,000 $11,000
Q2 2018 Jul 30, 2018	SELL	$12.45 - $16.95 $369,640 - $503,245	-29,690 Reduced 64.38%	16,429 $210,000
Q1 2018 Apr 26, 2018	BUY	$8.1 - $19.5 $373,563 - $899,320	46,119 New	46,119 $779,000
Q4 2017 Jan 10, 2018	SELL	$6.65 - $9.25 $11,863 - $16,502	-1,784 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$4.45 - $8.55 $7,938 - $15,253	1,784	1,784 $13,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

242M

Call Options Held

1.78M

Put Options Held

1.56M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.36B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Iovance Biotherapeutics, Inc. Transaction History